Ibrutinib (imbruvica): a novel targeted therapy for chronic lymphocytic leukemia.
Year: 2014
Type: article
Abstract: Ibrutinib (Imbruvica): a novel targeted therapy for chronic lymphocytic leukemia.
Source: PubMed
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1566174797
